BFA
NYMX

BlackRock Fund Advisors’s Nymox Pharmaceutical Corp NYMX Stock Holding History

BlackRock Fund Advisors’s Portfolio NYMX Stock Details NYMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$191K Hold
71,496
– – ﹤0.01% 3434
2016
Q3 		$233K Buy
71,496
+8,903
+14% +$29.1K ﹤0.01% 3400
2016
Q2 		$210K Buy
+62,593
New +$154K ﹤0.01% 3434

Other funds holding NYMX

WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
WB
Webster Bank Waterbury, Connecticut $1.06B AUM 19.66% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
BAS
Brown Advisory Securities Baltimore, Maryland $27.3M AUM 10.67% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
GG
Gofen & Glossberg Chicago, Illinois $3.89B AUM 11.97% 1-Year Est. Return

BlackRock Fund Advisors's NYMX Position: Q4 2016 in Review

BlackRock Fund Advisors held its Nymox Pharmaceutical Corp (NYMX) position steady in Q4 2016 at 71,496 shares worth $191K. The position accounts for ﹤0.01% of the portfolio, ranked #3434.

BlackRock Fund Advisors first reported a position in NYMX in Q2 2016 and has held it in 3 quarters since. The position peaked at $233K in Q3 2016. 29 funds tracked by Wall St. Rank hold NYMX as of Q4 2016.

  • BlackRock Fund Advisors held 71,496 shares of Nymox Pharmaceutical Corp worth $191K as of Q4 2016.
  • BlackRock Fund Advisors left its Nymox Pharmaceutical Corp share count unchanged in Q4 2016.
  • Nymox Pharmaceutical Corp made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #3434 holding.
  • BlackRock Fund Advisors first reported a position in Nymox Pharmaceutical Corp in Q2 2016 and has held it in 3 quarters since.
  • BlackRock Fund Advisors's Nymox Pharmaceutical Corp position peaked at $233K in Q3 2016.
  • 29 funds tracked by Wall St. Rank held Nymox Pharmaceutical Corp as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.